·2026·[2][3][4][5]burden:Globocan2000[J].IntJCancer,2001,94(2):153—156.KlugSJ,WilmotteR,SantosC,eta1.TP53polymorphism,HPVinfectionandriskofcervicalcancer[J].CancerEpdemiolBiomar-kersPrey,2001,10(9):1009—1011.CastleP,WacholderS,ShermanM,eta1.Absoluteriskofasub—sequentabnormalpapsmearamongoncogenichumanpapillomavir—usDNA—positive,cytologicalnegativewoman[J].Cancer,2002,95(10):2145—2151.HildesheimA,WangSS.Hostandviralgeneticsandriskofcervi—calcancer:areview[J].ViresRes,2002,89(2):229—240.BoschFX.ManosMM,MunozN,eta1.Prevalenceofhuman[6][7]MODERNONCOLOGY.Oct.2010,VOI.18,NO.10papillomavimsincervicalcancer:aworldperspective[J].JNatCancerInst,1995,87:796—802.WellsSI,AronowBJ,WiseTM,eta1.Transcriptomesignatureofirreversiblesenescenceinhumanpapillomavims—positivecervicalcancercells[J].ProcNatAcadSci